Tyme Technologies (TYME) Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- AMC Entertainment (AMC) Enters $250M ATM Agreement
TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
February 4, 2021 8:00 AM ESTAnnounced Richie Cunningham as new Chief Executive Officer Presented data from TYME-88-Panc Study at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium Continued enrolling patients in multicenter randomized controlled TYME-88-Panc pivotal trial evaluating oral SM-88 as a potential treatment for third-line pancreatic cancer; full enrollment not expected before calendar year 2022 PanCAN enrolling patients in multicenter Precision Promise adaptive randomized Phase II/III registration-intent trial evaluating oral SM-88 as second-line monotherapy for pancreatic cancer Continued enrolling patients in Joseph Ahmed Foundations HopES Sarcoma investigator-initiated Phase II trial studying oral SM-88 as... More